These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31886867)

  • 21. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
    Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
    Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pathogenesis of primary central nervous system lymphoma.
    Kadoch C; Treseler P; Rubenstein JL
    Neurosurg Focus; 2006 Nov; 21(5):E1. PubMed ID: 17134111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma.
    Zhang R; Wei B; Hu Y; Lv W; Adilai A; Yang F; Zhang J; Cheng G
    Clin Lymphoma Myeloma Leuk; 2023 Apr; 23(4):291-302. PubMed ID: 36725383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology and new insights in central nervous system lymphomas.
    Lebrun L; Allard-Demoustiez S; Salmon I
    Curr Opin Oncol; 2023 Sep; 35(5):347-356. PubMed ID: 37439536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent Gene Mutations and Their Possible Roles in the Pathogenesis, Treatment and Prognosis of Primary Central Nervous System Lymphoma.
    Jin Q; Jiang H; Han Y; Li C; Zhang L; Zhang Y; Chai Y; Zeng P; Yue L; Wu C
    World Neurosurg; 2023 Feb; 170():99-106. PubMed ID: 36396049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
    Nakamura T; Tateishi K; Niwa T; Matsushita Y; Tamura K; Kinoshita M; Tanaka K; Fukushima S; Takami H; Arita H; Kubo A; Shuto T; Ohno M; Miyakita Y; Kocialkowski S; Sasayama T; Hashimoto N; Maehara T; Shibui S; Ushijima T; Kawahara N; Narita Y; Ichimura K
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):279-90. PubMed ID: 26111727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Central Nervous System Lymphoma (PCNSL) - A Rare and Unusual Presentation of Rapidly Progressive Major Cognitive Dysfunction.
    Nand L; Gupta D; Sharma S; Kumar S
    J Assoc Physicians India; 2021 Feb; 69(2):68-70. PubMed ID: 33527818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of immunoglobulin H gene rearrangement by polymerase chain reaction in primary central nervous system lymphoma.
    Kros JM; Bagdi EK; Zheng P; Hop WC; Driesse MJ; Krenacs L; Dinjens WN
    J Neurosurg; 2002 Dec; 97(6):1390-6. PubMed ID: 12507138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The outcome of ibrutinib-based regimens in relapsed/refractory central nervous system lymphoma and the potential impact of genomic variants.
    Wang S; Zhu Y; Qian X; Ding T; Yuan Y; Li Y; Wu H; Chen T
    Adv Clin Exp Med; 2023 Aug; 32(8):855-863. PubMed ID: 36881367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
    Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
    Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.
    Vater I; Montesinos-Rongen M; Schlesner M; Haake A; Purschke F; Sprute R; Mettenmeyer N; Nazzal I; Nagel I; Gutwein J; Richter J; Buchhalter I; Russell RB; Wiestler OD; Eils R; Deckert M; Siebert R
    Leukemia; 2015 Mar; 29(3):677-85. PubMed ID: 25189415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.
    Hattori K; Sakata-Yanagimoto M; Suehara Y; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Hasegawa Y; Chiba S
    Cancer Sci; 2018 Jan; 109(1):225-230. PubMed ID: 29151258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Array-based DNA methylation profiling of primary lymphomas of the central nervous system.
    Richter J; Ammerpohl O; Martín-Subero JI; Montesinos-Rongen M; Bibikova M; Wickham-Garcia E; Wiestler OD; Deckert M; Siebert R
    BMC Cancer; 2009 Dec; 9():455. PubMed ID: 20025734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathway analysis of primary central nervous system lymphoma.
    Tun HW; Personett D; Baskerville KA; Menke DM; Jaeckle KA; Kreinest P; Edenfield B; Zubair AC; O'Neill BP; Lai WR; Park PJ; McKinney M
    Blood; 2008 Mar; 111(6):3200-10. PubMed ID: 18184868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes.
    Gleissner B; Siehl J; Korfel A; Reinhardt R; Thiel E
    Neurology; 2002 Feb; 58(3):390-6. PubMed ID: 11839837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
    You H; Wei L; Kaminska B
    Cancer Lett; 2021 Jul; 509():121-129. PubMed ID: 33766752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Tim-1 in primary CNS lymphoma.
    Kishimoto W; Nishikori M; Arima H; Miyoshi H; Sasaki Y; Kitawaki T; Shirakawa K; Kato T; Imaizumi Y; Ishikawa T; Ohno H; Haga H; Ohshima K; Takaori-Kondo A
    Cancer Med; 2016 Nov; 5(11):3235-3245. PubMed ID: 27709813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary central nervous system lymphoma: Novel precision therapies.
    Mondello P; Mian M; Bertoni F
    Crit Rev Oncol Hematol; 2019 Sep; 141():139-145. PubMed ID: 31295667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.